Cochlear Molecular Imaging for Non-Invasive Endocochlear Potential Measurement

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is no non-invasive method to measure the endocochlear potential (EP) in vivo, which is crucial for understanding hearing loss, as existing methods are invasive and cannot be used clinically without causing cochlear damage.

Innovation Solution

Utilizing molecular/nuclear imaging techniques with Thallium-201 (201Tl) as a radiotracer in combination with Single Photon Emission Computed Tomography (SPECT) to visualize and quantify potassium ion concentration in the scala media, which is proportional to EP, enabling non-invasive measurement of cochlear function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If invasive measurement techniques are used to measure endocochlear potential, then measurement precision is improved, but object-affected harmful factors worsen due to cochlear damage

Engineering Contradiction:

Improveendocochlear potential measurementVSAvoidcochlear damage

Core Design Contradiction:

Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent uses potassium ion analogs (radiotracers such as 86Rb+, 201Tl+, 43K+) as intermediary substances to indirectly measure endocochlear potential. These radiotracers mimic potassium ion behavior and are transported into the scala media through the same mechanisms (Na+-K+-ATPase pumps, K+ channels) that transport actual potassium ions. By measuring the concentration distribution of these harmless radiotracers, the patent obtains EP information without causing cochlear damage.

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces invasive mechanical measurement methods with non-invasive nuclear imaging techniques. Instead of using micro-surgical approaches to directly measure electrical potential, the patent employs radiotracer uptake measurements combined with imaging modalities (SPECT, PET, or gamma camera) to indirectly determine endocochlear potential, thereby eliminating mechanical intrusion into the cochlea.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

2Object-affected harmful factors

If non-invasive imaging methods are used to measure potassium ion concentration, then object-affected harmful factors are reduced, but measurement precision deteriorates due to indirect measurement

Engineering Contradiction:

Improvecochlear damageVSAvoidpotassium ion concentration measurement

Core Design Contradiction:

Object-affected harmful factorsVSMeasurement precision

Solution Approach 1:

The patent changes the measurement parameter from direct electrical potential measurement to radiotracer concentration measurement. By selecting radiotracers with appropriate half-lives and emission characteristics (e.g., 86Rb+ with 18.6-hour half-life emitting beta particles and gamma rays), the patent optimizes the balance between measurement precision and patient safety. The radiotracer concentration is quantitatively correlated to potassium ion concentration through established transport mechanisms.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent employs quantitative imaging techniques that provide feedback on radiotracer distribution in the cochlea. By measuring the intensity of radiation signals from different regions of the scala media and comparing them to reference values or control subjects, the system can quantitatively assess potassium ion concentration and endocochlear potential with improved precision.

Inventive Principle:

Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables non-invasive assessment of cochlear health and function, providing diagnostic and therapeutic avenues for hearing disorders by quantifying potassium ion concentration, thereby guiding treatment interventions.

Implementation Method 1

Nuclear and molecular imaging techniques are widely used to study biological processes in organs... The radioisotope can circulate throughout the body and/or can be taken up by only certain specific tissues. Its distribution can be tracked according to the radiation emitted.

Methodology Applied

Scientific EffectRadioactive Tracing: Radioactive Tracing

Implementation Method 2

201Tl is monovalent like K+ and has similar ionic radii, so, it can exchange with K+ readily

Methodology Applied

Scientific EffectIon Exchange: Ion Exchange

Implementation Method 3

Its distribution can be tracked according to the radiation emitted. This emitted radiation can be captured by various imaging techniques, such as single photon emission computed tomography (SPECT) or positron emission tomography (PET)

Methodology Applied

Scientific EffectSingle Photon Emission Computed Tomography: Tomography

Data Source

PatentUS12433549B1Molecular imaging of the cochlea

Publication Date: 2025.10.07 H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC

AI summary

A novel method of measuring endocochlear potential and cochlear function in a patient is presented. The method uses nuclear imaging, such as PET or SPECT, with a radiotracer such as 201Tl to visualize any potassium ion loss in the cochlea of the patient which can contribute to auditory disorders such as hearing loss. This non-invasive technique represents a new method for auditory diagnoses by measurement of cochlear properties which can aid in the development of new therapeutics for auditory disorders.